PURPOSE OF REVIEW: This review provides a brief update of new research findings on the role of vitamin D in multiple sclerosis (MS). RECENT FINDINGS: Evidence continues to accumulate supporting a protective role for vitamin D in MS risk and progression. Notable recent findings are that high 25-hydroxyvitamin D [25(OH)D] at the time of a first demyelinating event predicts a lower MS risk and a decreased risk of MS among offspring whose mothers had high predicted 25(OH)D levels. While a small vitamin D intervention study did not find an association between vitamin D and MS progression, this study had little statistical power, and larger trials will be needed to assess the therapeutic potential of vitamin D. Recent immunological studies also show modulation of the immune system by vitamin D that may be favorable for preventing or slowing the progression of MS. The demonstration that rare variants in CYP27B1, which encodes the enzyme that converts vitamin D to its active form, are strongly associated with MS risk supports a causal role of vitamin D deficiency as a risk factor for MS. SUMMARY: Research on the nature of the association between vitamin D and MS risk and progression continues to progress; however, additional research on the timing and dose-response relationship will be crucial for designing future prevention and treatment trials.
PURPOSE OF REVIEW: This review provides a brief update of new research findings on the role of vitamin D in multiple sclerosis (MS). RECENT FINDINGS: Evidence continues to accumulate supporting a protective role for vitamin D in MS risk and progression. Notable recent findings are that high 25-hydroxyvitamin D [25(OH)D] at the time of a first demyelinating event predicts a lower MS risk and a decreased risk of MS among offspring whose mothers had high predicted 25(OH)D levels. While a small vitamin D intervention study did not find an association between vitamin D and MS progression, this study had little statistical power, and larger trials will be needed to assess the therapeutic potential of vitamin D. Recent immunological studies also show modulation of the immune system by vitamin D that may be favorable for preventing or slowing the progression of MS. The demonstration that rare variants in CYP27B1, which encodes the enzyme that converts vitamin D to its active form, are strongly associated with MS risk supports a causal role of vitamin D deficiency as a risk factor for MS. SUMMARY: Research on the nature of the association between vitamin D and MS risk and progression continues to progress; however, additional research on the timing and dose-response relationship will be crucial for designing future prevention and treatment trials.
Authors: Andreas P Lysandropoulos; Emilie Jaquiéry; Samantha Jilek; Giuseppe Pantaleo; Myriam Schluep; Renaud A Du Pasquier Journal: J Neuroimmunol Date: 2010-12-24 Impact factor: 3.478
Authors: Christopher G Mayne; Justin A Spanier; Lance M Relland; Calvin B Williams; Colleen E Hayes Journal: Eur J Immunol Date: 2011-02-01 Impact factor: 5.532
Authors: Sarah-Michelle Orton; Sreeram V Ramagopalan; Andrea E Para; Mathew R Lincoln; Lahiru Handunnetthi; Michael J Chao; Julia Morahan; Katie M Morrison; A Dessa Sadovnick; George C Ebers Journal: J Neurol Sci Date: 2011-03-26 Impact factor: 3.181
Authors: J M Gelfand; B A C Cree; J McElroy; J Oksenberg; R Green; E M Mowry; J W Miller; S L Hauser; A J Green Journal: Neurology Date: 2011-05-24 Impact factor: 9.910
Authors: Anne C Looker; Christine M Pfeiffer; David A Lacher; Rosemary L Schleicher; Mary Frances Picciano; Elizabeth A Yetley Journal: Am J Clin Nutr Date: 2008-12 Impact factor: 7.045
Authors: Minke H W Huibers; Douwe H Visser; Martine M L Deckers; Natasja M van Schoor; A Marceline van Furth; Bart H M Wolf Journal: Eur J Pediatr Date: 2013-11-21 Impact factor: 3.183
Authors: Julia Pakpoor; Brandon Seminatore; Jennifer S Graves; Teri Schreiner; Amy T Waldman; Timothy E Lotze; Anita Belman; Benjamin M Greenberg; Bianca Weinstock-Guttman; Gregory Aaen; Jan-Mendelt Tillema; Jamie C McDonald; Janace Hart; Jayne M Ness; Yolanda Harris; Jennifer Rubin; Meghan Candee; Lauren Krupp; Mark Gorman; Leslie Benson; Moses Rodriguez; Tanuja Chitnis; Soe Mar; Ilana Kahn; John Rose; Suzan L Carmichael; Shelly Roalstad; Michael Waltz; T Charles Casper; Emmanuelle Waubant Journal: Mult Scler Date: 2017-06-13 Impact factor: 6.312